Pharmaceuticals
Quarterly Result31 March 2026 at 02:11 pm

Cipla Ltd. to Approve Q4 and FY26 Financial Results on May 13, 2026

AI Summary

Cipla Ltd. has announced that its Board of Directors will meet on May 13, 2026, to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and year ended 31st March 2026. The meeting will also recommend final dividend for the year ended 31st March 2026, if any. The Company's 'Trading Window' for dealing in securities will be closed from April 1, 2026, to May 15, 2026, for the financial results' purpose.

Key Highlights

  • Cipla Ltd. to approve Q4 and FY26 financial results on May 13, 2026
  • The meeting will consider and approve audited financial results for the quarter and year ended 31st March 2026
  • The Board will recommend final dividend for the year ended 31st March 2026, if any
  • Trading Window for dealing in securities closed from April 1, 2026, to May 15, 2026